Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

serb s.a. - e 132 indigotin i - injektionsvæske, opløsning - 40 mg

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - natriumibandronatmonohydrat - filmovertrukne tabletter - 150 mg

Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

astrazeneca ab - natrium zirconium cyclosilicate - hyperkaliæmi - alle andre terapeutiske produkter - lokelma er indiceret til behandling af hyperkalaemia i voksne patienter.

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - natriumibandronatmonohydrat - filmovertrukne tabletter - 150 mg

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - natriumibandronatmonohydrat - filmovertrukne tabletter - 50 mg

Danimarka - Daniż - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - natriumvalproat - depotkapsler, hårde - 150 mg

Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid modificerende midler - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasonpropionat - astma - medicin for obstruktiv sygdomme, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - medicin for obstruktiv sygdomme, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.